Granules India Resolves USFDA Observation at Virginia Facility
Granules India has received a clean slate from the USFDA for its Virginia facility, marking a positive turn after recent regulatory challenges. The company announced...
Tag : Granules India
Granules India Shares Gain 2% on 1 Observation from USFDA
Shares of Granules India Ltd were trading 2% higher on 23 June after the company announced receiving one observation from the US FDA for its...
Granules Shares Gain 2% on USFDA Approval
Shares of Granules India Ltd were trading 2% higher on 30 April after it announced receiving approval from the US health authorities to market a...
Granules India Receives USFDA Approval for Hypertension Drug
Granules India on 3 October announced that it had received approval from USFDA (the US Food and Drug Administration) for its Hypertension treatment tablets. The...
Granules India Shares Rise on Approval from Japanese, Brazilian Drug Regulators
Shares of Granules India were bullish during the early morning intraday session of 25 August after the company announced that it had received an accreditation...
Granules Pharma Clears USFDA Inspection; Shares rally 2%
Shares of Granules India rallied up 2% in early trade on August 4 after the company completed an inspection by the USFDA (United States Food...
Granules India Reviews Approval From USFDA For its Acetaminophen and Ibuprofen Tablets
Granules India Limited announced on July 14 that the US Food & Drug Administration (USFDA) had approved its drug application filed by Granules Pharmaceuticals, Inc,...
Granules India Gets FDA Nod for Hypertension Drug, But Shares Fall
Shares of Granules India erased their opening gains and traded lower in the first hours of trading on Monday despite the US Food and Drug...
Equity Mutual Fund Flows Moderate in July, Maruti Suzuki Tops
Equity mutual funds (MFs) stopped buying stocks in July despite a 9% rise in the benchmark index. Last month, they only invested Rs 4,712 crore...
Granules India receives USFDA nod for Methylergonovine tablets
Granules India has received USFDA’s approval for Methylergonovine 0.2 mg tablets. The abbreviated new drug applications (ANDA) was filed by Granules Pharmaceuticals Inc., a wholly...